Bausch Health Companies | VRX - Trade Debtors

Stock Price
7.01
Daily Change
-0.10 -1.41%
Monthly
-13.56%
Yearly
-30.11%
Q1 Forecast
6.65

Bausch Health Companies reported $2.35B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Amgen USD 9.57B 1.08B Dec/2025
ANI Pharmaceuticals USD 281.08M 28.46M Dec/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Bausch Health Companies USD 2.35B 66M Dec/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Corcept Therapeutics USD 59.79M 9.84M Dec/2025
Danaher USD 3.91B 762M Dec/2025
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Pacira USD 124.07M 8.8M Dec/2025
Perrigo USD 612.8M 31.6M Dec/2025
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 190.46M 8.54M Dec/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025
Zoetis USD 1.59B 49M Dec/2025